OTCMKTS:ORHOF

CannaRoyalty Competitors

$9.23
+5.18 (+127.81 %)
(As of 01/17/2020)
Add
Compare
Today's Range
$9.23
Now: $9.23
$9.23
50-Day Range
$9.23
MA: $9.23
$9.23
52-Week Range
$2.60
Now: $9.23
$9.75
Volume500 shs
Average Volume187,800 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

CannaRoyalty (OTCMKTS:ORHOF) Vs. DDXS, TNGN, ATTBF, ACHL, ADTX, and AGNPF

Should you be buying ORHOF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to CannaRoyalty, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), Achilles Therapeutics plc American Depositary Shares (ACHL), ADiTx Therapeutics (ADTX), and Algernon Pharmaceuticals (AGNPF).

(DDXS) (OTCMKTS:DDXS) and CannaRoyalty (OTCMKTS:ORHOF) are both health technology companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability.

Earnings and Valuation

This table compares (DDXS) and CannaRoyalty's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
CannaRoyaltyN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for (DDXS) and CannaRoyalty, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
CannaRoyalty0000N/A

Profitability

This table compares (DDXS) and CannaRoyalty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
CannaRoyaltyN/AN/AN/A

(TNGN) (OTCMKTS:TNGN) and CannaRoyalty (OTCMKTS:ORHOF) are both health technology companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.

Analyst Ratings

This is a breakdown of recent ratings and price targets for (TNGN) and CannaRoyalty, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
CannaRoyalty0000N/A

Profitability

This table compares (TNGN) and CannaRoyalty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
CannaRoyaltyN/AN/AN/A

Valuation & Earnings

This table compares (TNGN) and CannaRoyalty's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
CannaRoyaltyN/AN/AN/AN/AN/A

Abattis Bioceuticals (OTCMKTS:ATTBF) and CannaRoyalty (OTCMKTS:ORHOF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Abattis Bioceuticals and CannaRoyalty, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
CannaRoyalty0000N/A

Profitability

This table compares Abattis Bioceuticals and CannaRoyalty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
CannaRoyaltyN/AN/AN/A

Valuation & Earnings

This table compares Abattis Bioceuticals and CannaRoyalty's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
CannaRoyaltyN/AN/AN/AN/AN/A

Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) and CannaRoyalty (OTCMKTS:ORHOF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, analyst recommendations, valuation and risk.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Achilles Therapeutics plc American Depositary Shares and CannaRoyalty, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Achilles Therapeutics plc American Depositary Shares0000N/A
CannaRoyalty0000N/A

Profitability

This table compares Achilles Therapeutics plc American Depositary Shares and CannaRoyalty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Achilles Therapeutics plc American Depositary SharesN/AN/AN/A
CannaRoyaltyN/AN/AN/A

Earnings and Valuation

This table compares Achilles Therapeutics plc American Depositary Shares and CannaRoyalty's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Achilles Therapeutics plc American Depositary SharesN/AN/AN/AN/AN/A
CannaRoyaltyN/AN/AN/AN/AN/A

ADiTx Therapeutics (NASDAQ:ADTX) and CannaRoyalty (OTCMKTS:ORHOF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends and analyst recommendations.

Profitability

This table compares ADiTx Therapeutics and CannaRoyalty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ADiTx TherapeuticsN/AN/AN/A
CannaRoyaltyN/AN/AN/A

Earnings and Valuation

This table compares ADiTx Therapeutics and CannaRoyalty's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ADiTx TherapeuticsN/AN/AN/AN/AN/A
CannaRoyaltyN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings for ADiTx Therapeutics and CannaRoyalty, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ADiTx Therapeutics00103.00
CannaRoyalty0000N/A

Summary

ADiTx Therapeutics beats CannaRoyalty on 1 of the 1 factors compared between the two stocks.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and CannaRoyalty (OTCMKTS:ORHOF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Algernon Pharmaceuticals and CannaRoyalty, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Algernon Pharmaceuticals0000N/A
CannaRoyalty0000N/A

Profitability

This table compares Algernon Pharmaceuticals and CannaRoyalty's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Algernon PharmaceuticalsN/AN/AN/A
CannaRoyaltyN/AN/AN/A

Earnings and Valuation

This table compares Algernon Pharmaceuticals and CannaRoyalty's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algernon PharmaceuticalsN/AN/AN/AN/AN/A
CannaRoyaltyN/AN/AN/AN/AN/A


CannaRoyalty Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.01+53.8%$0.00N/A0.00High Trading Volume
Gap Up
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02+2.6%$0.00N/A0.00
ACHL
Achilles Therapeutics plc American Depositary Shares
0.0$13.78+5.3%$0.00N/A0.00
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.94+0.7%$0.00N/A0.00
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.15+1.2%$0.00N/A0.00Gap Down
Almirall logo
LBTSF
Almirall
0.5$15.00+1.3%$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08+0.0%$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01+0.0%$0.00N/A0.00Gap Up
ASCLF
Ascletis Pharma
0.4$0.37+0.0%$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06+0.0%$0.00N/A0.00
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.65+3.0%$0.00N/A0.00
BXRXV
Baudax Bio
0.5$4.51+22.2%$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.52+10.2%$0.00N/A0.00Gap Up
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.25+14.0%$0.00N/A0.00Gap Up
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.06+31.9%$0.00N/A0.00Gap Up
CGYG
China Longyi Group International
0.4$0.00+0.0%$0.00N/A0.00High Trading Volume
CLVLY
Clinuvel Pharmaceuticals
1.0$22.86+1.6%$0.00N/A0.00
CELZ
Creative Medical Technology
0.5$0.05+7.9%$0.00N/A0.00Gap Up
Cybin logo
CLXPF
Cybin
1.0$1.34+1.5%$0.00N/A0.00Gap Up
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00+75.0%$0.00N/A0.00High Trading Volume
Gap Up
EMMBF
Emblem
0.6$1.40+1.4%$0.00N/A0.00
ENZC
Enzolytics
0.0$0.23+18.0%$0.00N/A0.00Gap Up
GB Sciences logo
GBLX
GB Sciences
0.5$0.06+1.9%$0.00N/A0.00
Genfit logo
GNFTF
Genfit
0.5$4.65+4.7%$0.00N/A0.00Gap Up
GMXAY
GENMAB A/S/S
0.5$18.35+0.9%$0.00N/A0.00
Genus logo
GENSF
Genus
0.7$69.40+7.0%$0.00N/A0.00Gap Up
HALB
Halberd
0.0$0.04+5.7%$0.00N/A0.00Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.58+1.0%$0.00N/A0.00Gap Down
Idorsia logo
IDRSF
Idorsia
0.5$27.18+0.7%$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5$18.70+0.5%$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6$4.88+1.6%$0.00N/A0.00High Trading Volume
News Coverage
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.27+0.7%$0.00N/A0.00Gap Down
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.03+5.3%$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00+10.0%$0.00N/A0.00Gap Up
Mesoblast logo
MEOBF
Mesoblast
0.5$1.67+3.5%$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.38+5.7%$0.00N/A0.00News Coverage
Gap Up
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.69+3.0%$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$24.70+5.2%$0.00N/A0.00Gap Up
MPSYF
MorphoSys
0.0$88.15+13.4%$0.00N/A0.00Gap Up
NRNVF
Nordic Nanovector ASA
0.0$1.64+0.0%$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$65.81+0.3%$0.00N/A0.00
BPSR
Organicell Regenerative Medicine
0.5$0.06+2.6%$0.00N/A0.00
Oxurion logo
TBGNF
Oxurion
0.5$2.75+1.4%$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$4.11+4.4%$0.00N/A0.00High Trading Volume
Gap Up
PTEO
Proteo
0.5$178.00+1.0%$0.00N/A0.00High Trading Volume
PROT
Proteonomix
0.5$0.01+4.2%$0.00N/A0.00
PKTX
ProtoKinetix
0.5$0.25+2.1%$0.00N/A0.00High Trading Volume
Gap Down
PureTech Health logo
PTCHF
PureTech Health
0.0$5.85+1.9%$0.00N/A0.00
RCPHF
Recipharm AB (publ)
1.0$16.05+8.5%$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.